Histogen Presents Feasibility Data on Hair Growth and Laser Resurfacing
prnewsnow.com     May 17, 2008            

Histogen Inc a regenerative medicine company developing solutions based on the products of newborn fibroblasts today presented findings from preliminary evaluations of the Companys HGEN001 formulation during International Investigative Dermatology 2008 taking place May 1417 2008 in Kyoto... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Tattoo who? Legitimate parlors would welcome state health regulation to weed out unsafe and...

naples-daily-news.com     11 hrs ago          

Go to jail.” Body piercing is regulated by the state health department. “I think that is one idea that is included in this proposal, to do more regulation, to get it under the Department of Health,” said Ed Golding, an...                

comments

                   

MacroChem Announces Phase 2 Data For EcoNail(R) In The Treatment Of Onychomycosis

medicalnewstoday.com     yesterday   7 related          

MacroChem Corporation (OTC Bulletin Board: MACM) announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical...                

comments

                   

Sun Sense South Shore Skin Center Offer Sun Tips for Wellness and Anti-aging

sanepr.com     yesterday   6 related          

RSS feed for South Shore Skin Center: USA July 25, 2008 -- When selecting a sunscreen or sunblock, the dermatologists recommend the use of a broad spectrum UVA/UVB protection sunscreen or sunblock. South Shore Skin Center...                

comments

Beacon Equity Issues Technical Trade Alerts on Market Movers: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX

emailwire.com     yesterday          

DALLAS, Texas - Today’s Trade Alerts include: DUSA Pharmaceuticals Inc. (Nasdaq: DUSA), MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK), NovaMed Inc. (Nasdaq: NOVA), Adolor Corp. (Nasdaq: ADLR), Affymetrix Inc. (Nasdaq: AFFX)...                

comments